Difference between revisions of "Team:William and Mary/Description"
Line 164: | Line 164: | ||
<div><p style="float: right;"><IMG SRC="https://static.igem.org/mediawiki/2015/9/97/WMdCasDiag.jpeg" width=600px></p><p> | <div><p style="float: right;"><IMG SRC="https://static.igem.org/mediawiki/2015/9/97/WMdCasDiag.jpeg" width=600px></p><p> | ||
− | (RIGHT)Schematic of dCas9/CRISPR system. gRNAs targeting the promoter region of the gene of interest will guide dCas9 binding. Bound dCas9 sterically hinders RNAP and transcription factors from binding and promoting transcription [1].</p> | + | (RIGHT) Schematic of dCas9/CRISPR system. gRNAs targeting the promoter region of the gene of interest will guide dCas9 binding. Bound dCas9 sterically hinders RNAP and transcription factors from binding and promoting transcription [1].</p> |
<p>In addition to characterizing the noise of promoters in iGEM, we contributed additional tools for manipulating their expression. CRISPR/Cas9 has been used extensively in synthetic biology, both inside and out of iGEM. In particular, new functionalizations of the Cas9 protein that remove its catalytic nuclease domain while retaining its DNA-binding activity have allowed for novel methods in molecular biology. This catalytically inactive variant of Cas9, known as dCas9, can be used to repress gene expression by targeting the promoter region of a gene of interest. This repression is mediated by the CRISPR/Cas9 complex binding to the promoter region and can block RNAP binding or prevent transcriptional elongation. All of our gRNAs prevent RNAP binding and initiation of transcription.</p></div></p> | <p>In addition to characterizing the noise of promoters in iGEM, we contributed additional tools for manipulating their expression. CRISPR/Cas9 has been used extensively in synthetic biology, both inside and out of iGEM. In particular, new functionalizations of the Cas9 protein that remove its catalytic nuclease domain while retaining its DNA-binding activity have allowed for novel methods in molecular biology. This catalytically inactive variant of Cas9, known as dCas9, can be used to repress gene expression by targeting the promoter region of a gene of interest. This repression is mediated by the CRISPR/Cas9 complex binding to the promoter region and can block RNAP binding or prevent transcriptional elongation. All of our gRNAs prevent RNAP binding and initiation of transcription.</p></div></p> | ||
Revision as of 11:53, 18 September 2015
Integrator Suites
Detail1
Detail2
Detail3
Detail4
text
text
Antibiotic Operons
Detail1
Detail2
Detail3
Detail4
text
text
dCas9s
Detail1
Detail2
Detail3
Detail4
text
text
gRNAs
Detail1
Detail2
Detail3
Detail4
text
text
XFPs Under Various Promoters
Detail1
Detail2
Detail3
Detail4
text
text
G^2
Detail1
Detail2
Detail3
Detail4
text
text